Glucose News and Research

RSS

Research uncovers link between diet and blood cell markers of heart attack associated inflammation

New research further illuminates the heart-healthy benefits of the Mediterranean diet, tying the eating plan to lower levels of platelets and white blood cells, two markers of inflammation. Inflammation has an association with greater risk of heart attack and stroke.

1 Apr 2014

Bariatric surgery more effective than intensive medical therapy for managing type 2 diabetes

Gastric bypass and sleeve gastrectomy - two of the most commonly used bariatric surgeries - are more effective than intensive medical therapy alone when it comes to managing uncontrolled type 2 diabetes in overweight or obese patients after three years, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.

1 Apr 2014

Young adults with cardiac risk factors have worse cognitive function in middle age

Young adults with such cardiac risk factors as high blood pressure and elevated glucose levels have significantly worse cognitive function in middle age, according to a new study by dementia researchers at UC San Francisco.

1 Apr 2014

Halozyme meets primary endpoint in Hylenex CONSISTENT 1 trial

Halozyme Therapeutics, Inc. today announced that the primary endpoint of non-inferiority of A1C levels at six months was met for the CONSISTENT 1 trial. The trial is evaluating Hylenex® recombinant and a new formulation of Hylenex currently under U.S Food and Drug Administration (FDA) review, when used as pretreatment of the insulin infusion site in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion (CSII) in comparison to no pre-treatment.

31 Mar 2014

Bariatric surgery patients report better quality of life

A study by Cleveland Clinic researchers shows bariatric surgery is a highly effective and durable treatment for type 2 diabetes in obese patients, enabling nearly all surgical patients to be free of insulin and many to be free of all diabetic medications three years after surgery.

31 Mar 2014

Newly identified protein markers have potential to contribute to better understanding of heart disease

Researchers at the Intermountain Medical Center Heart Institute in Murray, Utah, have discovered that elevated levels of two recently identified proteins in the body are inflammatory markers and indicators of the presence of cardiovascular disease.

31 Mar 2014

Aleglitazar drug does not reduce risk of cardiovascular events in patients with type 2 diabetes

Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death, heart attack or stroke among patients with type 2 diabetes and recent heart attack or unstable angina, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions.

31 Mar 2014

Study: Adolescents with stronger muscles have lower risk of heart disease and diabetes

Adolescents with stronger muscles have a lower risk of heart disease and diabetes, according to a new study that examined the influence of muscle strength in sixth grade boys and girls.

31 Mar 2014

Integral Molecular announces new patent protecting use of lipoparticles for eliciting antibodies against protein targets

Integral Molecular, a leader in membrane protein antibody discovery, announces the issuance of a new patent protecting the use of Lipoparticles for eliciting antibodies against membrane protein targets.

29 Mar 2014

Study links effect of gastric bypass surgery on glucose metabolism and islet function in hypoglycemia patients

University of Cincinnati (UC) researchers have discovered that altered islet cell function and reduced insulin clearance contribute to excessive post-meal insulin response in patients experiencing low blood sugar symptoms (hypoglycemia) following gastric bypass surgery.

29 Mar 2014

Polymer Technology Systems changes its name to Chek Diagnostics

Polymer Technology Systems, Inc. (PTS, Inc.), the U.S.-based manufacturer of point-of-care diagnostic products, announced today that it is changing its name to Chek Diagnostics.

27 Mar 2014

Echo Therapeutics reports net loss of $3.9M in fourth quarter 2013

Echo Therapeutics, Inc., a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced financial results for the year ended December 31, 2013.

27 Mar 2014

New strain of rice may help combat obesity and other diseases

In recent years, Okinawa has recorded the dubious distinction of having the highest obesity rate in Japan. Preventing obesity-related diseases is an urgent issue.

27 Mar 2014

BD Micro-Fine Ultra Pen Needle with Pentapoint technology launched in the UK and Ireland

BD (Becton, Dickinson and Company), a leading global medical technology company, announced today the launch in the UK and Ireland of BD Micro-Fine Ultra with 5-bevel needle technology, clinically demonstrated to improve injection comfort for diabetes patients, and enhancing the injection advantages of the current BD Micro-Fine+ Pen Needle.

From BD (Becton, Dickinson and Company) 27 Mar 2014

Expert highlights the importance of gender-specific approach for treating diabetes mellitus

The international guidelines on the drug-based therapy of diabetes mellitus specify which factors need to be taken into account during treatment.

27 Mar 2014

Researchers explore link between diet, metabolic homeostasis and air pollutant exposure

Is air pollution connected with increases in obesity, diabetes, and chronic kidney disease? Researchers are providing insight into that question today at the Society of Toxicology 53rd Annual Meeting and ToxExpo in Phoenix, Ariz.

26 Mar 2014

People with type 2 diabetes who report good self-management behavior have reduced mortality risk

People with type 2 diabetes who report good self-management behavior have a reduced mortality risk. This was the result of a population-based study conducted by scientists at Helmholtz Zentrum München emphasizing the great importance of patient behavior in the diabetes treatment process.

26 Mar 2014

Sufficient sleep can prevent and reverse metabolic disorders

Evidence increasingly suggests that insufficient or disturbed sleep is associated with metabolic disorders such as type 2 diabetes and obesity, and addressing poor quality sleep should be a target for the prevention – and even treatment – of these disorders, say the authors of a Review, published in The Lancet Diabetes & Endocrinology journal.

26 Mar 2014

New mathematical model predicts blood glucose levels with more than 90% accuracy

A mathematical model created by Penn State researchers can predict with more than 90 percent accuracy the blood glucose levels of individuals with type 1 diabetes up to 30 minutes in advance of imminent changes in their levels -- plenty of time to take preventative action.

26 Mar 2014

Diabetes drug reduces amyloid-beta peptides, improves memory in experimental AD models

Researchers from Boston University School of Medicine have found that the diabetic drug, pramlintide, reduces amyloid-beta peptides, a major component of Alzheimer's disease (AD) in the brain and improves learning and memory in two experimental AD models.

25 Mar 2014

Glucose News and Research

Research uncovers link between diet and blood cell markers of heart attack associated inflammation

Bariatric surgery more effective than intensive medical therapy for managing type 2 diabetes

Young adults with cardiac risk factors have worse cognitive function in middle age

Halozyme meets primary endpoint in Hylenex CONSISTENT 1 trial

Bariatric surgery patients report better quality of life

Newly identified protein markers have potential to contribute to better understanding of heart disease

Aleglitazar drug does not reduce risk of cardiovascular events in patients with type 2 diabetes

Study: Adolescents with stronger muscles have lower risk of heart disease and diabetes

Integral Molecular announces new patent protecting use of lipoparticles for eliciting antibodies against protein targets

Study links effect of gastric bypass surgery on glucose metabolism and islet function in hypoglycemia patients

Polymer Technology Systems changes its name to Chek Diagnostics

Echo Therapeutics reports net loss of $3.9M in fourth quarter 2013

New strain of rice may help combat obesity and other diseases

BD Micro-Fine Ultra Pen Needle with Pentapoint technology launched in the UK and Ireland

Expert highlights the importance of gender-specific approach for treating diabetes mellitus

Researchers explore link between diet, metabolic homeostasis and air pollutant exposure

People with type 2 diabetes who report good self-management behavior have reduced mortality risk

Sufficient sleep can prevent and reverse metabolic disorders

New mathematical model predicts blood glucose levels with more than 90% accuracy

Diabetes drug reduces amyloid-beta peptides, improves memory in experimental AD models

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News